跳至主要内容
临床试验/NCT02555267
NCT02555267已完成不适用

Multi-center, Prospective Cohort Study to Investigate the Impact of Comprehensive Geriatric Assessments on Survival and Toxicities in Elderly Diffuse Large B-cell Lymphoma Patients Treated With R-CHOP

Chonbuk National University Hospital1 个研究点 分布在 1 个国家目标入组 148 人开始时间: 2015年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
148
试验地点
1
主要终点
Event-free survival

研究概览

简要总结

This study investigate the impact of comprehensive geriatric assessments using activity of daily living (ADL), instrumental activity of daily living (IADL), and Charlson's comorbidity index (CCI) on survival and toxicities in Korean patients with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with newly diagnosed CD20+ DLBCL
  • 65 years old or over
  • Scheduled to receive R-CHOP chemotherapy
  • Informed consent

排除标准

  • Other histology than CD20+ DLBCL
  • Primary central nervous system DLBCL
  • Patients with a diagnosis of cancer (other than basal or squamous cell carcinoma of the skin, cervical carcinoma in situ, well differentiated thyroid cancer [papillary or follicular thyroid cancer]) within 3 years before the study entry or with any treatment for cancer within 3 years before entry
  • Consent withdrawal

结局指标

主要结局

Event-free survival

时间窗: 2 years

Event-free survival was defined as death, relapse from complete remission, progression during or after treatment, and discontinuation or changes of therapy during treatments

次要结局

  • Overall survival(5 years)
  • Progression-free survival(5 years)
  • Cumulative incidence of grade 3/4 adverse events and premature treatment discontinuation(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ho-Young Yhim

Assistant professor

Chonbuk National University Hospital

研究点 (1)

Loading locations...

相似试验

Geriatric Assessments in Elderly Diffuse Large... | 临床试验